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Abstract
Genome-wide association studies (GWAS) and subsequent dense-genotyping of associated loci identified over a hundred
single-nucleotide polymorphism (SNP) variants associated with the risk of rheumatoid arthritis (RA), type 1 diabetes (T1D),
and celiac disease (CeD). Immunological and genetic studies suggest a role for CD4-positive effector memory T (CD
+ TEM)
cells in the pathogenesis of these diseases. To elucidate mechanisms of autoimmune disease alleles, we investigated
molecular phenotypes in CD4
+ effector memory T cells potentially affected by these variants. In a cohort of genotyped
healthy individuals, we isolated high purity CD4
+ TEM cells from peripheral blood, then assayed relative abundance,
proliferation upon T cell receptor (TCR) stimulation, and the transcription of 215 genes within disease loci before and after
stimulation. We identified 46 genes regulated by cis-acting expression quantitative trait loci (eQTL), the majority of which
we detected in stimulated cells. Eleven of the 46 genes with eQTLs were previously undetected in peripheral blood
mononuclear cells. Of 96 risk alleles of RA, T1D, and/or CeD in densely genotyped loci, eleven overlapped cis-eQTLs, of
which five alleles completely explained the respective signals. A non-coding variant, rs389862
A, increased proliferative
response (p=4.75610
28). In addition, baseline expression of seventeen genes in resting cells reliably predicted proliferative
response after TCR stimulation. Strikingly, however, there was no evidence that risk alleles modulated CD4
+ TEM abundance
or proliferation. Our study underscores the power of examining molecular phenotypes in relevant cells and conditions for
understanding pathogenic mechanisms of disease variants.
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Introduction
Memory T cells are an important component of the adaptive
immune system. They circulate between lymphoid organs, blood,
and peripheral tissues, and facilitate faster and more aggressive
immune response to antigens after re-exposure. CD4-positive
effector memory T (CD4
+ TEM) cells are known to migrate to
peripheral sites of inflammation upon activation, and rapidly
produce both Th1 and Th2 cytokines [1]. Investigators have long
suggested their involvement in autoimmune diseases including
rheumatoid arthritis (RA), type I diabetes (T1D), and celiac disease
(CeD) [2–5]. However, whether changes in cell population subsets
and functions are causal or reactive to disease is uncertain. One
strategy to answer this question is to examine potential interme-
diate molecular phenotypes, and identify those modulated by
genetic variants. In order to understand the pathogenic roles of
CD4
+ TEM cells in autoimmunity, we aimed to characterize the
variation in their phenotypic and functional markers in a healthy
PLOS Genetics | www.plosgenetics.org 1 June 2014 | Volume 10 | Issue 6 | e1004404population, and to identify whether these markers intersect with
the genetic basis for autoimmunity.
The majority of autoimmune disease risk variants are located in
non-coding regions of the genome. It is reasonable to hypothesize
that a subset of them causes disease by altering gene regulatory
mechanisms as expression quantitative trait loci (eQTL) [6–9]. So
far, studies of gene regulation have largely been carried out in cell
lines and primary resting blood cells including undifferentiated
CD4
+ T cells, B cells, monocytes, and dendritic cells [8,10–12].
However, to understand the pathogenic mechanisms of risk
variants, especially when studying the immune system where cells
are highly diverse and functionally specialized, it is crucial to focus
on relevant cell types and stimulated cellular states.
Wehave previouslyshownthat genes withinRArisk loci weremost
specifically expressed in CD4
+ TEM cells, compared to more than 200
other immune cell types of various lineages and developmental stages
(p=1.00 610
28; Figure S1) [13]. Celiac disease and T1D loci were
also enriched for genes specifically expressed in CD4
+ TEM cells
(p=1.43 610
25 and 1.29610
24, respectively; Figure S1)[ 1 3 ] .N o n -
coding single nucleotide polymorphisms (SNPs) associated with RA
significantly overlap chromatin marks of trimethylation of histone H3
atlysine4(H3K4me3)specificallyinCD4
+regulatory and memory T
cells (p=1.3 610
24 and 7.0610
24, respectively) [14].
We hypothesized that the risk alleles of these conditions might
influence CD4
+ TEM quantitative molecular phenotypes: 1) the
expression of immune-related genes; 2) the relative abundance of
CD4
+ TEM cells in peripheral blood; and 3) proliferative response
to T cell receptor (TCR) stimulation. To this end, we undertook a
large immunoprofiling study in a healthy population of 174
European-descent individuals, by cross-analyzing genotype, tran-
scription, abundance, and proliferative response in primary CD4
+
TEM cells. Because the post-stimulation activation of CD4
+ TEM
cells is presumably crucial for their autoimmune response, we
assayed cells not only at rest, but also after T cell receptor (TCR)
stimulation with anti-CD3/CD28 beads. As such, this study is the
first to our knowledge to map expression quantitative trait loci and
examine immunological cellular traits in primary CD4
+ TEM cells
under multiple states.
Using the ImmunoChip platform, investigators recently densely
genotyped 186 loci disease that originally arose through genome-
wide association studies (GWAS) in case-control samples for RA,
CeD, and inflammatory bowel disease [15–17], as well as T1D
(unpublished data). Dense genotyping allowed localization of
association signals within these disease loci to a set of alleles that
are very likely to be causal. Within these loci, we have a greater
ability to identify co-localization between alleles driving variation
in molecular phenotypes (such as eQTLs) and the disease risk
alleles. However, in instances where multiple variants are in
perfect linkage, we cannot pinpoint the exact causal variant
without functional evaluation.
Results
The experimental protocol (Figure 1) is described in detail in
Methods and Text S1. Briefly, we obtained peripheral blood
mononuclear cells (PBMCs) from the whole blood of healthy
individuals via Ficoll-Paque centrifugation, and then used mag-
netic- and fluorescence-activated cell sorting to isolate CD4
+ TEM
cells at a high degree of purity (.90%; see Figure S2A). We
acquired genome-wide genotype data of about 640,000 SNPs on
Illumina Infinium Human OmniExpress Exome BeadChips [18].
For each individual we then measured three quantitative
phenotypes: 1) the expression of 215 genes (see Table S1) before
and after T cell receptor (TCR) stimulation by anti-CD3/CD28
antibody beads; 2) the relative abundance of CD4
+ TEM cells
(CD45RA
2/CD45RO
+/CD62L
2/low) as a proportion of total
CD4
+ T cells; and 3) proliferation upon stimulation. Since we had
low numbers of primary cells for expression profiling, we used the
highly sensitive NanoString nCounter assay to avoid biases
potentially induced by cDNA preparation. Out of the 215 genes
assayed, 115 were within densely genotyped disease risk loci (see
Tables S2 and S3). We quantified CD4
+ TEM cell abundance
with X-Cyt, an automated statistical method that accurately
identifies cell populations in cytometry data [19].
Mapping cis-eQTLs that regulate genes in risk loci
We first aimed to identify SNP variants that regulated
expression of genes in cis. To best localize eQTL signals, we
imputed 1000 Genomes variants within 250 kb from the
transcription start site (TSS) of each gene (excluding five HLA
genes and five long non-coding RNAs). We tested SNPs in gene-
coding and non-coding regions in both resting and stimulated
CD4
+ TEM cells. We included gender and the top five principal
components of the genotype data (calculated by EIGENSTRAT)
as covariates in regression. To adjust for multiple hypothesis
testing, we conducted 10,000 permutations within each gene
region to calculate empirical p-values, and then reported
associations at a false discovery rate of 5%.
In total, we observed 46 genes (22.4%) with cis-eQTL signals,
including 17 in resting cells and 43 in stimulated cells (Tables 1
and 2, Figure 2A). For 14 of the 46 genes (30.4%), we detected
eQTL signals in both resting (14/17, 82.4%) and stimulated (14/
43, 32.6%) states. In four of these 14 genes (FHL3, GRB10,
IL18R1, and PIGC), the lead eQTL SNPs across resting and
stimulated states were identical. In another five genes (C1QTNF6,
PRDM1, SKAP2, DDX6, and LYRM7), the lead SNPs are in tight
LD (r
2=0.80,1; based on 1000 Genomes Release 2, European
samples). For the remaining five genes (BLK, TMPRSS3, CD101,
ORMDL3, and GSDMB), the lead SNPs from the two states were in
partial LD (0.42,r
2,0.56). In these five cases, we could not be
confident that the eQTL SNPs across stimulation states were
tagging the same variant.
Author Summary
Genome-wide association studies have identified hun-
dreds of genetic variants associated to autoimmune
diseases. To understand the mechanisms and pathways
affected by these variants, follow-up studies of molecular
phenotypes and functions are required. Given the diversity
of cell types and specialization of functions within the
immune system, it is crucial that such studies focus on
specific and relevant cell types. Here, we studied genetic
and cellular traits of CD4-positive effector memory T (CD4
+
TEM) cells, which are particularly important in the onset of
rheumatoid arthritis, celiac disease, and type 1 diabetes. In
a cohort of healthy individuals, we purified CD4
+ TEM cells,
assayed genome-wide single nucleotide polymorphisms
(SNPs), abundance of CD4
+ TEM cells in blood, proliferation
upon T cell receptor stimulation, and 215 gene transcripts
in resting and stimulated states. We found that expression
levels of 46 genes were regulated by nearby SNPs,
including disease-associated SNPs. Many of these expres-
sion quantitative trait loci were not previously seen in
studies of more heterogeneous peripheral blood cells. We
demonstrated that relative abundance and proliferative
response of CD4
+ TEM cells varied in the population,
however disease alleles are unlikely to confer risk by
modulating these traits in this cell type.
Autoimmune Alleles and eQTLs in CD4 Effector Memory T Cells
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significant eQTLs exclusively in the resting state, while 29 genes
had statistically significant eQTLs exclusively in stimulated cells,
such as rs942793 associated with ZMIZ1 expression (Figure 2B).
One possibility is that some SNPs failed to reach significance
threshold due to the small sample size or low expression levels in
resting cells. However, we observed many genes with truly state-
specific eQTLs, where the estimated effect sizes (b) of the eQTL
SNP differed significantly across resting and stimulated states. To
systematically compare the brest and bstim for each gene, we used a
z-statistic to quantify the probability that they differ. We then
reported the p-value (two-tailed) assuming that z is distributed as
standard normal, considering p,0.05 to be significantly different
(‘‘state-specific’’; see Tables 1 and 2). For example, rs12746918
T
increased the expression of PLCH2 significantly only in resting
cells; and brest was approximately twice as large as bstim
(Figure 2C). We note that 1 of the 3 eQTLs in resting cells
was state-specific (p,0.05), and 13 out the 29 eQTLs seen in
stimulated cells were state-specific (p,0.05). Of the 14 eQTLs that
were shared between resting and stimulated cells, only 4 of them,
BLK (Figure 2D), CD101, PIGC, and PRDM1, had different b’s
across states. The abundance of eQTLs detected exclusively in
stimulated cells underscores the importance of studying cells in
different cellular states.
We wanted to assess whether the eQTLs might act by altering
gene regulatory elements in CD4
+ TEM cells. To this end we asked
whether the eQTL SNPs co-localized with marks of active
promoters or enhancers. We utilized H3K4me3 marks from the
NIH Roadmap Epigenomics Mapping Consortium [20] measured
by ChIP-seq in primary CD4
+ memory T cells. For the SNP with
thestrongestassociationto eachgene,wequeriedthe distance ofthe
nearest H3K4me3 mark to thisSNPorits LDpartners (r
2.0.8). We
compared this distance measure between two sets of SNPs: the 46
SNPs with significant eQTL associations (FDR,5%, resting or
stimulated), and the SNPs most strongly correlated with the other
159 genes but did not reach significance threshold. Indeed, the 46
significant eQTL SNPs were located at smaller distances to
H3K4me3 marks (p=1.10610
27, one-sided Mann-Whitney test,
Figure S3A). In addition, we queried the height of each H3K4me3
mark’s peak, which reflected the number of reads at a given position
compared to genomic controls as defined by the MACS software
package. A tall peak gives us confidence that the mark is presentin a
large proportion of cells. Comparing the marks nearest to the two
sets of SNPs, we saw that the 46 eQTL SNPs were also located near
taller peaks (p=9.56610
28, Figure S3B).
Many eQTLs are CD4
+ TEM cell-specific
We compared the cis-eQTLs we discovered to those found in
heterogeneous peripheral blood mononuclear cells (PBMC) in a
large genome-wide eQTL meta-study (n=5,331) conducted by
Westra et al. [8]. At 5% FDR, eleven of the 46 eQTL genes we
identified showed no detectable signal in PBMCs at 50% FDR.
We saw significant associations in 131 genes at 50% FDR, 53 of
which had no signal in PBMCs at 50% FDR (Tables 1 and 2).
We hypothesized that these genes tended to be more specifically
expressed in CD4
+ TEM cells, thus making eQTLs readily
detectable in the purified cell population. To assess this, we
examined cell-specific expression of the genes the ImmGen
dataset, which assayed the genome-wide expression in 247 murine
mouse immunological cell types [13,21]. We found that the genes
with CD4
+ TEM cell-specific eQTLs (at 50% FDR) were more
specifically expressed in CD4
+ TEM cells than genes with eQTLs
detected in both datasets (p=0.044, one-sided Mann-Whitney
test).
Autoimmune disease alleles affect the transcription of
genes in cis
We then focused on 115 genes near 96 risk alleles of RA, T1D,
and/or CeD in densely genotyped loci (182 gene-SNP pairs,
including two risk alleles shared by at least two diseases, see
Tables S2 and S3). We discovered that eleven (11.4%) disease-
associated SNPs (6 of 24 RA SNPs, 5 of 37 T1D SNPs, and 3 of 37
CeD SNPs) correlated significantly with the expression of ten
genes in either resting or stimulated state (Table S3). In addition,
there was substantial enrichment of nominally significant associ-
ations (p,0.05) among disease SNPs. By random chance, we
expected about nine SNP-gene pairs to reach nominal association
Figure 1. Schematic of the experimental workflow. We collected
four types of data from each individual: 1) quality-controlled genome-
wide SNP data containing 638,347 markers collected on Illumina
Infinium Human OmniExpress Exome BeadChips, 2) abundance of CD4
TEM cells as a percentage of all CD4 T cells obtained by FACS and
quantified by X-Cyt, 3) average cell division upon T cell receptor
stimulation by anti-CD3/CD28 commercial beads, measured using a
CFSE (carboxyfluorescein succinimidyl ester) dye dilution assay, and 4)
expression of 215 genes measured by NanoString nCounter. We
repeated each proliferation assay in two-three technical replicates. Cell
sorting purity and replication correlations for CD4 TEM abundance,
division index, and proliferation index are shown in Figure S2.
doi:10.1371/journal.pgen.1004404.g001
Autoimmune Alleles and eQTLs in CD4 Effector Memory T Cells
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with nominal association in resting cells (p=4.67610
27, one-tailed
binomial test). Even more strikingly, we observed 45 pairs (24.7%)
with nominal association in stimulated cells (p,10
215, one-tailed
binomial test).
To identify those instances where the disease-associated SNP
could explain the entire eQTL signal in the gene region, we
applied conditional analysis to identify any residual signals after
controlling for the disease SNP. In five of the ten genes (BLK,
C5orf30, GSDMB, IRF5, PLEK), conditioning on the disease SNP
obviated any remaining eQTL signal in the region (no SNP with
permutation p-value ,0.05; Figure 3), suggesting that there was a
single variant (the disease-associated SNP or one in very high LD
to it) that drove variation in expression. Interestingly, as previously
noted, the lead SNPs in resting and stimulated states for BLK and
GSDMB were in partial linkage to each other. The absence of
residual eQTL signal upon conditioning on the same risk allele
might suggest that the lead SNPs were indeed tagging the same
causal SNP in each of these genes. In each of the other five genes
(ORMDL3, SKAP2, TMPRSS3, TNFRSF14, and ZMIZ1), evidence
of independent eQTL effect remained after conditional analysis.
In these instances the disease-associated SNP and remaining lead
signal are in partial linkage disequilibrium (r
2=0.36–0.73). In
these cases, we could not conclude whether the disease SNPs drove
the alteration in expression, or whether the true causal SNPs were
in partial linkage and caused spurious associations. It is probable
that disease risk alleles were indeed causal, yet we could not
confidently fine-map the effect due to experimental noise in
expression assays or inadequate sampling.
We note that another 26 genes within disease loci associated
contained cis-eQTL signals, but that these cis-eQTL signals did not
co-localize with RA, T1D, or CeD alleles. As these loci had been
fine-mapped using Immunochip, the lack of overlap strongly
suggested that these cis-eQTLs and disease-causing variants were
distinct. For example, rs798000 is an RA risk allele located in a
non-coding region upstream of CD2, CD58, and PTGFRN.
However, it was not associated with the expression of any of
these genes (p.0.5). Another example was rs6911690, an RA
allele located about 60 kb 59 of PRDM1, that was not associated
with the expression of the gene at rest or after stimulation (p.0.5).
The lead eQTL SNP associated to PRDM1 was rs578653 (FDR,
10
23), which was not in LD with the disease allele (r
2,0.05).
Figure 2. State-specific effects of eQTL SNPs. A) For a subset of genes, the correlation effects (b) of the top associated SNP across resting and
stimulated cells differed. The genes shown with a black-dotted vertical lines had significantly different effect sizes across states. Black horizontal
segments in B)–D) denote median values. Blue panels show resting-state (normalized) expression values; red panels show stimulated expression
values. B) rs942793
G significantly increased the expression of ZMIZ1 only in stimulated cells. C) rs12746918
T was correlated with increased expression
of PLCH2 in resting cells only. D) rs4840565
C decreased BLK expression in stimulated cells nearly twice as much as in resting cells [brest(SE)=2
0.366(0.085), bstim=20.805(0.071)].
doi:10.1371/journal.pgen.1004404.g002
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+ TEM cell proliferation
The relative peripheral abundance of CD4
+ TEM cells varied
between individuals (mean=9.57%; SD=4.85%), and was
reproducible 35 individuals with two separate blood draws more
than one month apart (Pearson’s r=0.87, p=1.77610
211, see also
Figure S2B). Consistent with other studies, we observed that the
relative proportion of CD4
+ TEM cells increased with age by
0.11% per year (page=1.92610
23) [22]. We also observed that on
average men had 2.22% more CD4
+ TEM cells than women
(pgender=3.80610
22; see Figure S4). Upon anti-CD3/CD28
stimulation, there was a substantial inter-individual variation in
proliferation measured by both division index (DI, average
number of divisions undergone by all cells; mean=1.46,
SD=0.35), and proliferation index (PI, average number of
divisions undergone only by dividing cells; mean=2.16,
SD=0.21). Proliferation metrics were also reproducible in the
35 individuals (Pearson’s rDI=0.57; Pearson’s rPI=0.62, Figures
S2C and S2D). Interestingly, proliferation was negatively
correlated to the proportion of CD4
+ TEM cells
(pDI=1.28610
23, pPI=1.93610
23), but was not associated to
age or gender (p.0.3). This negative correlation needs to be
replicated in an independent dataset. Effector functions of TEM
cells with higher proliferative capacities need to be examined to
understand whether they represent a hyperactive subset whose
abundance is controlled to maintain immune homeostasis. Possibly
individuals with a lower proportion of TEM cells are relatively
enriched for these subsets.
We tested genome-wide SNPs for association to relative
abundance, division index, and proliferation index, considering
p,5610
28 as the threshold for significance. For abundance, we
included gender, age, and the top five principal components of
genotypes as covariates. Given the correlation with proliferation,
we also included the measured CD4
+ TEM relative abundance as
an additional covariate. We observed associations to division index
in several loci, including 13q34 led by rs389862 (p=4.75610
28;
Figure 4A). This SNP is a non-coding variant located 30 kb
upstream of RASA3, and 70 kb upstream from CDC16. Both genes
have known roles in regulating cell proliferation or differentiation
[23,24]. This SNP was also strongly associated with proliferation
index (p=2.75610
27). Additionally, there was a strongly sugges-
tive association to rs3775500 on chromosome 4, located in the
intron of DAPP1, which encodes the Bam32 protein
(p=5.40610
27; Figure 4B), which is an adaptor protein
expressed solely in antigen presenting B cells. Interestingly,
mutations in this gene have been shown by several groups to
affect T cell activation [25,26], suggesting the possibility that B
cells may indirectly regulate T cell function in autoimmunity. We
did not observe any significant association with the relative
abundance of CD4
+ TEM cells.
When we extracted the association statistics of 118 densely
genotyped risk alleles of CeD, RA, and/or T1D, they showed no
inflation in association p-values for relative abundance of CD4
+
TEM cells (Figure 5A, Table S2). This suggested that risk
variants did not modify risk via modulation of CD4
+ TEM
peripheral abundance. We recognized that the power to detect
significant associations might have been limited in our study by the
sample size. However, this negative finding was corroborated by
results from a recently published study with data from ,2800
individuals, in which the same set of risk alleles also showed no
significant association to CD4
+ TEM (see Figure S5) [27].
Similarly, the same set of risk alleles did not show significant
association to proliferative response (Figure 5B, Table S2).
Based on these data, it was unlikely that SNP variants associated to
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+
TEM cell abundance or proliferation.
Gene expression in resting cells predicted post-TCR
stimulation proliferation
After stimulation we observed that 122 genes showed significant
changes in expression in response to stimulation, including 78
whose expression at least doubled or decreased by 50% (Table
S1). The gene with the greatest post-stimulation induction was
GZMB (average fold change=93.48), which encodes granzyme B,
a protein involved in the apoptosis of target cells during cell-
mediated immune response in cytotoxic and memory lympho-
cytes. The most significantly down-regulated gene was GRB10
(average fold change=0.18), which is near rs6944602 associated
with T1D and encodes growth factor receptor-bound protein 10,
whose function in the immune system is unclear.
We observed that relative gene expression at rest predicted
proliferative response. In 182 individuals with both proliferation
and gene expression data, 17 of the 215 genes were associated
with proliferation index (p,0.01, two-tailed test by permuting
Figure 3. Five disease risk alleles explained the eQTL associations with five genes. The left-sided panels show unconditional SNP-
expression association results. Green dashed lines mark the TSS of the eQTL gene. The red dots indicate the risk alleles associated with the expression
of respective genes shown as red arrows. The right-sided panels show adjusted association results after conditioning for the respective risk alleles. In
each of the five loci, conditioning on the disease SNP obviated signals in the entire region, such that no association more significant than p=0.05
remains.
doi:10.1371/journal.pgen.1004404.g003
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15 of the 17 genes including CCR5, IL2RB, PRR5L, and TBX21,
were correlated with reduced proliferative response, while CCR9
and the lncRNA XLOC_003479 showed significant correlation
with increased proliferation. This number of correlated genes was
far in excess of random chance based on a null distribution
consisting of 1000 permutations (p,10
23, median 2, maximum
15). The weighted sum of the 17 genes served as a ‘‘proliferation
potential signature’’, where we weighted the positively- and
negatively-correlated genes as +1 and 21, respectively. This
signature strongly predicted proliferation index (r=0.55). We
show the correlation between each of the 17 genes as well as the
aggregate signature to proliferation as a heatmap (Figure 6A). To
assess if we were overfitting the data, we applied a two way cross-
validation, where we defined the proliferation signature based on
genes from half of the individuals and tested correlation to
proliferation in the remaining half of the individuals. In both
instances we again observed significant prediction of proliferation
(r=0.41,one tailed p,10
23 by permutation; r=0.39, p,10
23).
To search for biological pathways underlying genes correlated
to proliferation, we applied gene set enrichment analysis (GSEA)
to test for enrichment for 1,008 functional gene sets based on Gene
Ontology codes [28] (Figure 6B). Genes correlated to reduced
proliferation were most significantly enriched for GO:0012502
(induction of programmed cell death; one tailed p=1.8610
24);
those correlated with increased proliferation were most signifi-
cantly enriched for GO:0002285 (lymphocyte activation involved
in immune response, one tailed p=3.9610
24).
Figure 6. Relationship between baseline expression and post-
stimulatory response. A) Baseline expression of 17 genes correlated
with post-stimulation proliferation. Rows in the heatmap are ordered
from top to bottom by ascending proliferation index. Genes/columns
are ordered from the most negatively correlated (IL23RB) to the most
positively correlated (CCR9). The 17-gene signature was calculated as
the weighted sum of the 17 genes, where the negatively-correlated
genes were given a weight of 21, and the positively-correlated genes
were given a weight of +1. Table S1 lists the correlation coefficient and
p-value for each gene. B) Genes correlated with proliferative response
were enriched for apoptosis and lymphocyte activation pathways.
Genes correlated to lower proliferative response (proliferative index)
were enriched for Gene Ontology code GO:0012502 (induction of
programmed cell death, p=1.8610
24). Conversely, genes correlated to
higher proliferative response were enriched for GO:0002285 (lympho-
cyte activation, p=3.9610
24).
doi:10.1371/journal.pgen.1004404.g006
Figure 4. Genome-wide association to division index (the
average number of division undergone by all cells). A)
rs389862
A on chromosome 13 was significantly associated to increased
division index at p=4.75610
28, and is located in a non-coding region
30 kb upstream of RASA3, and 70 kb upstream from CDC16. B)
rs3775500
G on chromosome 4 shows a strongly suggestive association
at p=5.40610
27, and is located within the DAPP1 (Bam32) gene.
doi:10.1371/journal.pgen.1004404.g004
Figure 5. Risk alleles of CeD, RA, and T1D, showed no
significant association to CD4 TEM cell abundance or prolifer-
ation. A) The 118 SNPs with association to diseases in densely
genotyped regions on Immunochip platform were not significantly
associated to CD4 TEM cell abundance. The shaded region shows 95%
confidence interval. See also Figure S5. B) The same set of 118 risk
alleles also showed no inflation in association with proliferative
response measured as division index.
doi:10.1371/journal.pgen.1004404.g005
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at least one month apart, we replicated the observed correlation.
In these samples we performed a cross-visit analysis, and observed
that the same 17-gene signature from the first visit significantly
predicted proliferation indices on the second visit (r=0.65,
p=0.0006, 1-tailed permutation), and vice versa (r=0.55, p=0.0019).
Discussion
To fine-map and link risk loci to their pathogenic mechanisms,
we investigated molecular and immune phenotypes potentially
leading to disease end-points. The immune system is particularly
complex, and different cells under various activation states have
specialized functions that may not be adequately captured by
examining PBMCs. Therefore, we focused on one purified cell
population that had been shown to be important for the patho-
genesis of several autoimmune diseases. We quantified population
variation in several traits, including peripheral abundance,
proliferative response to TCR stimulation, and expression of
genes within autoimmune disease loci at rest and after stimulation.
In Tables 1, 2, and S2, we provide significant cis-eQTLs and
genome-wide association results.
To our knowledge this study was a first cross-examination of
genetic-, transcriptional-, and cellular-level quantitative traits in
CD4
+ TEM cells. It demonstrated the importance of focusing
functional studies in a purified cell population under relevant
developmental and stimulation states. By examining the prolifer-
ative response upon TCR stimulation, we identified a subset of
genes whose baseline expression predicted proliferative potential.
Intriguingly, these genes were involved in programmed cell death
and lymphocyte activation. Whether variation in proliferative
abilities correlated with cytokine production and other signaling
functions, thus affecting susceptibility to autoimmunity, remains a
question to be addressed by future studies.
Of the 205 genes in disease loci that we examined, 46 had cis-
eQTLs. Notably, eleven of these were specific to stimulated CD4
+
TEM cells, and not previously found in PBMCs. We noted that
approximately 10% of genes within risk loci of diseases had cis-
eQTLs. However in many instances the lead eQTL SNPs were
unrelated to the disease-associated SNPs. One example of a
disease allele that functioned as cis-eQTL was rs39984, which was
associated to lower risk of RA, and regulated the expression of
C5orf30 encoding an UNC119-binding protein. This SNP variant
is located in the first intron of C5orf30, and indeed explained the
entire cis-eQTL signal in this gene (see Figure 2B). This eQTL
effect was previously undetected in PBMCs, and the protein’s
functional role in the immune system is largely unknown.
However, a recent study showed that rs26232 (the lead GWAS
SNP prior to fine-mapping, r
2=0.988 to rs39984) was correlated
with lower severity of radiologic damage in RA, independent of
previously established biomarkers [29]. Another gene in the locus,
GIN1, is located 140 kb from rs39984; however its expression
showed no correlation with the SNP (p.0.5).
Another CD4
+ TEM cell-specific eQTL gene was DDX6, which
encodes DEAD-box RNA helicase 6. However, in this case, the
lead eQTL SNP (rs4938544) associated to increased expression of
DDX6 in stimulated cells was not in LD with the known CeD risk
allele (rs10892258, r
2,0.1) or the RA risk allele (rs4938573, r
2,
0.1). Neither risk allele showed significant association to DDX6
expression (p=0.19 and 0.26, respectively). Both risk alleles are
also located near CXCR5, BCL9L, and TREH; none of these genes
had reported cis-eQTLs in PBMCs [8]. However, we did not assay
these three genes in this study, therefore could not confirm the role
of disease alleles in regulating their expression in CD4
+ TEM cells.
Although we did not assay all genes or test for trans-acting
eQTLs, based on the level of co-localization between eQTL SNPs
and risk alleles observed in the study, we found it unlikely that all
non-coding risk variants caused disease by altering gene expression
within resting or stimulated CD4
+ TEM cells. In addition, while
changes in proportions of lymphocyte subsets had been observed
in patients of autoimmune disorders [30–35], we did not find
evidence to support disease alleles’ roles in directly modulating
CD4
+ TEM cell abundance or proliferative response. Ultimately,
other cell states and cell types will need to be investigated.
We recognize several limitations to the current study. In order
to conduct a focused study on a small amount of purified primary
cells we used the NanoString nCounter assay system. This avoided
potential biases and artifacts arising from cDNA synthesis required
for microarray or RNA-seq studies, but restricted our analysis to a
subset of candidate genes within risk loci of CeD, RA, and T1D,
rather than a genome-wide expression analysis. Consequently we
could not identify trans-eQTLs, splice variants, or epistatic effects
on expression regulation. Additionally, anti-CD3/CD28 stimula-
tion for memory T cells is not antigenic, especially while in
isolation from a ‘‘natural’’ multi-cellular environment, thus it was
only partially physiological.
This and other cell-specific studies on population variation in
molecular phenotypes are only a beginning of examining potential
intermediate phenotypes. Post-activation cytokine production by
CD4
+ TEM cells are likely crucial in driving autoimmunity.
Therefore, it is critical that future studies of molecular phenotypes
include proteomic assays to quantify functional markers of immune
response. Finally, functional experiments will need to be conducted
in the future to determine whether these molecular phenotypes are
indeed intermediary to disease.
Materials and Methods
Ethics statement
All research was approved by our Institutional Review Board,
and informed consent was obtained from each volunteer.
Study sample
We enrolled 225 healthy volunteers (134 females, 91 males) of
non-Hispanic Caucasian descent that proved informed consent
through the Phenogenetics Project at Brigham and Women’s
Hospital. Subjects’ ages ranged from 19 to 57 years with average
female and male ages of 28.8 years and 34.9 years, respectively.
Thirty-five subjects (18 females, 17 males) returned for a second
study visit one to nine months after their initial visits.
Genotyping
We genotyped each subject using the Illumina Infinium Human
OmniExpress Exome BeadChip. In total, we genotyped 951,117
SNPs, of which 704,808 SNPs are common variants (minor allele
frequency [MAF].0.01) and 246,229 are part of the exome. After
quality control, 638,347 common SNPs remained. Of all subjects,
174 subjects had abundance, proliferation, gene expression, and
quality controlled genotype data. Detailed quality control criteria
are described in Text S1.
SNP imputation
For each gene, we selected a 500 kb region (250 kb each in the
39 and 59 directions) around the transcription start site and
imputed 1000 Genomes SNPs into the genome-wide SNP data
using BEAGLE Version 3.3.2. We used the European samples
from 1,000 Genomes as the reference panel. We excluded markers
that had MAF,0.05 in the reference panel as well as all insertion/
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R
2,0.4 or MAF,0.01 in the imputed samples.
CD4
+ TEM cell isolation and stimulation
We isolated peripheral blood mononuclear cells (PBMC) from
whole blood using a Ficoll density gradient (GE Healthcare). We
then isolated CD4
+ effector memory T cells from PBMCs first by
magnetic-activated cell sorting to enrich for CD4
+ T cells, followed
by fluorescent-activated cell sorting using labeled antibodies
against CD45RA, CD45RO, and CD62L.
We stimulated CD4
+ TEM cells by incubation with commercial
anti-CD3/CD28 beads for 72 hours. For proliferation studies, we
labeled cells with carboxyfluorescein diacetate succinimidyl ester
(CFSE; eBioscience), and measured proliferation by dye dilution.
Detailed isolation and purification methods are described in Text
S1 (also see Figure S2A).
Gene expression
We designed the NanoString codeset based on GWAS SNPs
associated with CeD, RA, and T1D as of April 2012. This list of
SNPs can be found in Supplementary Table S4. As the
numbers of associated loci with autoimmune diseases continuously
expand, we refer the reader to ImmunoBase (https://www.
immunobase.org) for up-to-date disease regions. For each locus,
we defined a region of interest implicated by the GWAS lead SNP
[36]. We identified the furthest SNPs in LD in the 39 and 59
directions (r
2.0.5). We then extended outward in each direction
to the nearest recombination hotspot. If no genes were found in
this region, we extended an additional 250 kb in each direction.
All genes overlapping this region were considered implicated by
the locus. The final NanoString codeset (prior to expression data
quality control) included 312 genes, including 270 genes near
SNPs associated with 157 RA, CeD, and T1D through GWAS, 26
genes of immunological interest, and 15 reference genes with
minimal change in expression after TCR stimulation (see
Supplementary Table S1).
After quality control, 215 genes remained. Of all 225 subjects in
the study, 187 subjects passed gene expression quality control for
both resting and stimulated cells. Specific normalization and
quality control procedures are described in Text S1.
Genotype principal component analysis
To control for any potential population stratification, we
adjusted all association tests using the top five principal
components of our genome-wide SNP data. Principal components
were generated via EIGENSTRAT using unsupervised analysis
(no reference populations were used). The top five PCs explained
6.88% (2.08%, 1.27%, 1.20%, 1.17%, and 1.16%, respectively) of
the total variance. After controlling for these five PCs, the lambda
GC for CD4 TEM proportion association was 1.008; that of
division index was 1.001.
Cis-eQTL analysis
For each gene-SNP pair, we applied linear regression using the
first five principal components of the genotype data and gender as
covariates. As such, normalized expression=b0+b1*allelic dosage+
b2*PC1+b3*PC2+b4*PC3+b5*PC4+b6*PC5+b7*(factor)gender. To
adjust for multiple hypothesis testing while taking into consider-
ation the correlation among SNPs within each locus, we calculated
a permutation-based p-value for each SNP. We performed 10,000
permutations of the residual expression values. We reported each
SNP’s p-value the proportion of permutation P value smaller than
the analytical p-value. For conditional analysis, the vector of allelic
dosages of the disease-associated SNP was included as an
additional covariate.
Quantification of CD4
+ TEM cells and proliferative
response
We defined CD4
+ TEM cells as CD45RA
2, CD45RO
+, and
CD62L
low/2. In all samples CD4
+ TEM cells were quantified using
X-Cyt, a mixture-modeling based clustering program for automat-
ed cell population identification (see Figure S6) [19]. We fit
proliferation division peaks with one-dimensional Gaussian
mixture models (see Figure S7). Detailed protocol and algorithms
are described in Text S1.
Statistical analysis
All linkage disequilibrium calculations (r
2) were based on 1000
Genomes Release 3 European samples. All association tests were
performed using Plink v1.07. We considered p,5610
28 to be
genome-wide significant; p,5610
25 was considered as suggestive.
CD4
+ TEM abundance and proliferation correlations with age and
gender were calculated by multivariate linear model implemented
in R-3.0. We calculated two-sample comparisons (CD4
+ TEM cell-
specific expression between genes, and H3K4me3 h/d scores
between SNPs) with the Mann-Whitney test. Details of statistical
analyses are described in Text S1.
Data access
We make all phenotypic data (expression, peripheral abundance,
and proliferation) along with eQTL results publicly available online
(http://immunogenomics.hms.harvard.edu/CD4eqtl.html). Ge-
nome-wide genotype data will become available through dbGAP
and through the ImmVar project. These data are potentially useful
to investigators wishing to assess the potential of genetic variants in
altering these molecular phenotypes.
Supporting Information
Figure S1 Enrichment of cell-specific expression of genes within
risk loci. As described in Hu et al. AJHG 2011, A) genes within risk
loci of RA were the most specifically expressed in CD4
+ TEM cells
(p=1.00610
28) followed by signal in regulatory T cells
(p=5.00610
28). B) Genes within CeD were also the most strongly
enriched in CD4 TEM cells (p=1.43610
25) followed by
regulatory T cells (p=3.78610
25). C) In T1D, CD8 memory T
cells showed the strongest enrichment (p=2.26610
25), followed
by regulatory T cells (p=5.13610
25) and CD4
+ TEM cells
(p=1.29610
24).
(TIFF)
Figure S2 A) Using a combination of magnetic and fluores-
cence-activated cell sorting (MACS and FACS), CD4
+ T cells were
isolated to a high degree of purity. The isolated population
contained ,97% CD3
+ cells, ,90% CD4
+ cells, ,0.4% CD8
+
cells, and ,0.03% CD19
+ cells. B) The relative abundance (as a
percentage of all sorted lymphocytes), C) division index (average
division of all cells), and D) proliferation index (average division of
all cells that went into division), were reproducible in 35
individuals with two blood draws at least one month apart.
Pearson’s r=0.87, 0.57, and 0.62, respectively.
(TIFF)
Figure S3 The 46 eQTL SNPs show more overlap with
H3K4me4 marks. A) Cis-eQTL SNPs were located nearer
H3K4me3 peaks in CD4 TEM cells than the 159 top SNPs that
did not reach statistical significance at 5% FDR (p=1.10610
27,
one-sided Mann-Whitney test). B) The 46 cis-eQTL SNPs were
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PLOS Genetics | www.plosgenetics.org 11 June 2014 | Volume 10 | Issue 6 | e1004404near larger H3K4me4 peaks (peak height) and located at smaller
distances to the summit of the peaks (p=9.56610
28, one-sided
Mann-Whitney test).
(TIFF)
Figure S4 The relative abundance of CD4 TEM cells as the
percentage of CD4 T cells. A) increased with age, at 0.11% per
year; and B) was correlated with gender, where men on average as
2.2% more CD4 TEM cells than women. The associations
remained significant in a multivariate linear regression.
(TIFF)
Figure S5 SNPs associated to CeD, RA, and T1D, showed no
significant association to CD4 TEM cell abundance. The 119 risk
alleles within densely genotyped loci showed no significant
association to CD4 TEM abundance as a percentage of CD4 T
cells in the study by Orru et al. The shaded area shows the 95%
confidence interval.
(TIFF)
Figure S6 Quantification of CD4 TEM cells using X-Cyt. A)I n
each sample of enriched CD4 T lymphocytes, X-Cyt clustered all
flow eventsbased on fluorescenceintensitiesinCD45RA,CD45RO,
and CD62L simultaneously, using a seven-component multivariate
Gaussian mixture-modeling. The TEM cell population is shown in
red, defined as CD45RA
2,C D 4 5 R A
+, and CD62L
low/2. B)X - C y t
clustered and quantified CD4 TEM cells in all samples (four random
samples are shown here) in the study following the template in A).
The TEM cell population is shown as the red cluster in each sample.
In Sample 3, the subset of the black population residing in the lower
left quadrant is the light green population identified as ‘‘debris’’ in
Panel A); they are CD62L
2, CD45RA
2,a n dC D 4 5 R O
2.
(TIF)
Figure S7 The CFSE intensity peak present in the pooled
resting wells for each subject (data underlying the green fitted
curve) was modeled as a single Gaussian distribution. Its mean and
variance were then used to initialize the location of the first
component (undivided cells) and the variance of all components in
each of the stimulated wells (data underlying the red fitted curve).
The CFSE dilution peaks from stimulated wells were fitted using a
one-dimensional mixture model of multiple Gaussian components
of equal peak-to-peak distance and equal variance via a gradient
descent optimization algorithm. A maximum of six components
(five divisions) was fitted to each stimulated well; the weight of each
component was allowed to be 0.
(TIF)
Table S1 Table S1 lists all genes included in the NanoString
codeset, including those that did not pass quality control for
downstream analyses. We list each gene’s relationship to GWAS
SNPs, resting and stimulated expression levels, as well as the
correlation between baseline expression and post-stimulation
proliferation.
(XLSX)
Table S2 Table S2 lists all densely-genotyped disease-associated
SNPs for CeD, RA, and T1D included in this study. We list each
SNP’s association to disease(s), nearby genes included in the study,
as well as association p-values to CD4
+ TEM relative abundance
and proliferation.
(XLSX)
Table S3 Table S3 lists the 182 (densely-genotyped disease-
associated) SNP-gene pairs included in the eQTL study. We list
each pair’s effect size and p-value in resting and stimulated states.
(XLSX)
Table S4 Table S4 contains all GWAS associated SNPs to CeD,
RA, and/or T1D, used for designing the NanoString codeset in
April 2012. For each gene, we list its lead SNP in LD, disease
association (to the lead SNP), GO code, and functional
description.
(XLSX)
Text S1 Text S1 includes detailed descriptions of materials,
experimental methods, and statistical analyses used in our study.
We provide protocols and analytical methods for 1) cell population
collection, isolation, staining, stimulation, flow cytometry, and
NanoString assays; 2) cell abundance and proliferation quantifi-
cation; and 3) gene selection, expression analysis, and eQTL
analysis.
(DOCX)
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